Dr. El Osta is leading the expansion of the precision oncology program and cutting edge clinical trials for the treatment of veterans with refractory thoracic and head and neck malignancies at Atlanta VA Medical Center. At Winship, he is conducting trials to understand the safety and efficacy of combining immune checkpoint inhibitors with anti-angiogenic agents in thoracic malignancies.
Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Badi El Osta, MD is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in medical oncology and palliative medicine, Dr. El Osta specializes in the prevention and treatment of head and neck, and lung cancers.
Since joining the Emory faculty in 2016, he has been actively involved in patient care and clinical research, as well as in the education of Emory University oncology fellows and medical residents at the Atlanta VA Medical Center.
Dr. El Osta serves as the chair of the Cancer Committee for the Atlanta VA Healthcare System. He is a clinical member of the Discovery and Developmental Therapeutics research program at the Winship Cancer Institute of Emory University. He also serves as a member of the Biomedical Committee of the Institutional Review Board at Emory University.
Dr. El Osta holds professional memberships with American Society of Clinical Oncology, Cancer Therapy Evaluation Program, and Eastern Cooperative Oncology Group.
Dr. El Osta received his MD from Saint Joseph's University School of Medicine in Beirut, Lebanon. He completed his residency at Good Samaritan Hospital in Cincinnati, Ohio. Thereafter, he completed three fellowships: Hematology/Oncology at the Medical College of Georgia in Augusta, Georgia; Investigational Cancer Therapeutics (phase 1 clinical trials) and Palliative Care at the University of Texas MD Anderson Cancer Center in Houston, Texas.
Dr. El Osta's research involves combining immune checkpoint inhibitors and anti-angiogenic agents to improve outcomes of patients with thoracic malignancies. He is also interested in the economics of phase I clinical trials, and in the identification of cost-control strategies to develop a more cost-effective organizational model.
Dr. El Osta has co-authored more than 15 peer reviewed scientific papers in leading journals including Cancer Discovery and Journal of Clinical Oncology. He has co-authored abstracts for presentation at national and international professional meetings.
Publications Publication Date
Dr. El Osta's awards and honors include:
- ASCO Foundation Pain Merit Award, 2006
- ASCO Foundation Oncology Merit Award, 2007
- Merck Investigator Studies Program, 2019